TA Associates has acquired a “significant” stake in India and New Jersey-based OmniActive, a provider of natural nutraceutical ingredients. No financial terms were disclosed.
Mumbai, India and Morristown, N.J., Jan 11, 2021 — OmniActive Health Technologies (“OmniActive” or “the Company”), which offers a wide range of premium, scientifically-validated, natural nutraceutical ingredients, today announced that TA Associates, a leading global growth private equity firm, has acquired a significant stake in the Company, while Founder and Executive Chairman Sanjaya Mariwala has further increased his personal holding. Financial terms of the transaction were not disclosed.
Established in 2005, OmniActive seeks to improve lives by enhancing nutrition and wellness through science and innovation. A leader in health solutions, the Company offers a range of premium natural ingredients that are innovative and scientifically-validated for dietary supplementation and nutritional fortification. OmniActive works with leading human nutrition brands and manufacturers across the world to improve the health and well-being of consumers through a solution-oriented approach. The Company has R&D and manufacturing operations in Pune, Hosur and Thane in India; and sales and distribution operations in the U.S., Europe, India, Asia, Australia and Latin America.
“We are pleased to welcome TA Associates as a strategic investor and partner for the next phase of OmniActive’s growth journey. We believe that TA has deep capabilities and experience investing in companies focused on nutritional ingredients, and shares OmniActive’s vision of bringing innovative, natural and science-based solutions to our customers and end consumers. We intend to leverage our strong management capabilities and TA’s distinctive M&A sourcing engine to drive programmatic M&A and in-licensing to continuously deliver innovation to our customers,” said Sanjaya Mariwala, Founder, Executive Chairman and Managing Director of OmniActive.
“We believe that the nutritional ingredients space will see strong growth over the next decade. OmniActive has built a strong reputation and deep customer relationships by focusing on natural, R&D-led innovative ingredients. We look forward to working together with Mr. Mariwala and the OmniActive management team to further accelerate the growth in this business through organic levers and M&A,” said Naresh Patwari, a Director at TA Associates Advisory Private Limited.
“We believe that TA’s global healthcare experience will be valuable in supporting OmniActive’s next phase of growth through continued organic growth and strategic acquisitions. OmniActive has been growing at an accelerated pace, driven by a portfolio of branded, innovative natural products with clinically supported health benefits, and we are excited to continue this growth journey and supporting our customers with TA as our new equity partner,” said Jim Hamilton, CEO of OmniActive.
“We are impressed by the quality of OmniActive’s business and customer franchise. We believe that OmniActive is well-placed to benefit from the strong growth in the nutraceuticals ingredients space, and look forward to our partnership,” said Dhiraj Poddar, a Managing Director at TA Associates Advisory Private Limited.
OmniActive Health Technologies, Everstone and Other Selling Shareholders were advised by Investec (sole Financial Advisor), DSK Legal and KPMG. TA Associates was advised by Houlihan Lokey USA, Shardul Amarchand Mangaldas and PriceWaterhouse Coopers.
About OmniActive Health Technologies
Established in 2005, OmniActive seeks to improve lives by enhancing nutrition and wellness through science and innovation. OmniActive’s extensive portfolio consists of natural, scientifically-validated, sustainable and IP-protected ingredients for global customers in dietary supplements and functional foods and beverages. Some of the Company’s leading brands include Lutemax®, Capsimax®, CurcuWIN®, Gingever, Xtenergy® and OmniXan®. OmniActive partners with customers through its sales and distribution networks in key markets worldwide, supported by three global R&D centers and best-in-class production facilities throughout India. The Company has offices in Mumbai, India and Morristown, New Jersey. For more information consult: www.omniactives.com
About Sanjaya Mariwala
Sanjaya Mariwala is a successful entrepreneur and business leader. Mr. Mariwala led Kancor Ingredients Ltd. previously, which he sold in 2014 to V Mane Fils of France. He is also a shareholder and director for various Mariwala Family enterprises, namely, Autohangar India Pvt Ltd, Food Service India Ltd., Setu Nutraceuticals and Edence Nutrition. Mr. Mariwala founded OmniActive in 2005 and has led the Company through its growth for the past 15 years. He currently serves as its Executive Chairman. In addition, he helped establish the Association of Herbal and Nutraceutical Manufacturers of India (AHNMI), and heads several initiatives within FICCI, CII, CRN and other industry shaping forums. Mr. Mariwala supports various charity initiatives with some notable examples being Vitamin Angels and OmniActive’s Improving Lives Foundation.
About TA Associates
TA Associates is a leading global growth private equity firm. Focused on targeted sectors within five industries – technology, healthcare, financial services, consumer and business services – TA invests in profitable, growing companies with opportunities for sustained growth, and has invested in more than 500 companies around the world. Investing as either a majority or minority investor, TA employs a long-term approach, utilizing its strategic resources to help management teams build lasting value in high-quality growth companies. TA has raised $33.5 billion in capital since its founding in 1968 and is committing to new investments at the pace of over $3 billion per year. The firm’s more than 100 investment professionals are based in Boston, Menlo Park, London, Mumbai and Hong Kong. More information about TA Associates can be found at www.ta.com.